Beyond opioids: The effect of prescription drug monitoring programs on non‐opioid drug prescribing.

A growing literature has examined how mandatory access prescription drug monitoring programs (MA PDMPs), laws that require providers to consider a patient's prescription history before prescribing controlled substances, affect opioid‐related outcomes. However, evidence of their impact on non‐opioid‐...

Descripción completa

Detalles Bibliográficos
Publicado en:Contemporary Economic Policy Vol. 43; no. 3; pp. 452 - 470
Autores principales: Beheshti, David, Kim, Bokyung
Formato: Artículo
Publicado: Wiley-Blackwell Jul2025
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=185862084&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 185862084
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        10743529
        CEY
      jtl: Contemporary Economic Policy
      issn: 10743529
      maglogo: Y
    pubinfo:
      dt: Jul2025
      vid: 43
      iid: 3
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        185862084
        10.1111/coep.12684
      ppf: 452
      ppct: 18
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
              size: 2.5MB
      tig:
        atl: Beyond opioids: The effect of prescription drug monitoring programs on non‐opioid drug prescribing.
      aug:
        au:
          Beheshti, David
          Kim, Bokyung
        affil:
          Department of Economics, University of Texas at San Antonio, San Antonio Texas,, USA
          Department of Economics, University of Connecticut, Storrs Connecticut,, USA
      su:
        Controlled substances
        Pharmacodynamics
        Drug prescribing
        Drug accessibility
        Benzodiazepines
      sug:
        subj:
          Controlled substances
          Pharmacodynamics
          Drug prescribing
          Drug accessibility
          Benzodiazepines
      keyword:
        benzodiazepines
        prescription drug monitoring programs
        stimulants
        benzodiazepines
        prescription drug monitoring programs
        stimulants
      ab: A growing literature has examined how mandatory access prescription drug monitoring programs (MA PDMPs), laws that require providers to consider a patient's prescription history before prescribing controlled substances, affect opioid‐related outcomes. However, evidence of their impact on non‐opioid‐related prescribing is mixed. This paper investigates the effect of MA PDMPs on prescribing patterns of stimulants and benzodiazepines. Using updated difference‐in‐differences methodology, we show that MA PDMPs led to decreases in stimulant prescribing but had no significant effects on benzodiazepine prescribing. Our findings highlight that MA PDMPs do have effects on non‐opioid drug prescribing, but these effects differ substantially across drug types.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N